hyperkalaemia

Showing 4 posts of 4 posts found.

astrazeneca_sign_sky

First for Japan with the approval of AstraZeneca’s Lokelma in hyperkalaemia

March 26, 2020
Sales and Marketing AstraZeneca, Astra|Zeneca, Japan, Lokelma, hyperkalaemia, pharma

Japan’s Ministry of Health, Labour and Welfare has awarded approval to AstraZeneca’s Lokelma for the treatment of hyerkalaemia, marking the …

astrazeneca_sign_sky

FDA approves AZ’s Lokelma for hyperkalaemia

May 21, 2018
Sales and Marketing AstraZeneca, FDA, Lokelma, hyperkalaemia, pharma

The FDA has revealed its decision to approve AstraZeneca’s oral potassium-removing agent Lokelma (sodium zirconium cyclosilicate) for the treatment of …

blood-1813410_960_720

AstraZeneca hit with second blow on $2.7 billion drug

March 17, 2017
Medical Communications AstraZeneca, FDA, hyperkalaemia

AstraZeneca paid $2.7 billion for ZS Pharma, back in 2015, with the desire to get its hands on the company’s …

astrazeneca image

AstraZeneca acquires ZS Pharma for $2.7bn, announces Q3 results

November 6, 2015
Medical Communications AstraZeneca, M&A, MA, ZS Pharma, ZS-9, acquisitions, financial results, hyperkalaemia, mergers

AstraZeneca has announced its acquisition of ZS Pharma for an all-cash total of $2.7 billion. In the latest mega-money deal …

Latest content